BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31368083)

  • 21. Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay.
    Thodou E; Kontogeorgos G; Kyrodimou E; Salla H; Ramyar L; Vamvassakis E; Piaditis G; Anagnostopoulos N; Tzanis S; Levedis A; Rologis D; Asa SL
    J Endocrinol Invest; 1999 Oct; 22(9):671-80. PubMed ID: 10595830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transsphenoidal surgery for growth hormone-secreting pituitary adenomas in 130 patients.
    Shirvani M; Motiei-Langroudi R
    World Neurosurg; 2014 Jan; 81(1):125-30. PubMed ID: 23313263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line.
    Asa SL; Kovacs K; Horvath E; Singer W; Smyth HS
    J Clin Endocrinol Metab; 1992 Jul; 75(1):68-75. PubMed ID: 1352308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cystic appearance on magnetic resonance imaging in bihormonal growth hormone and prolactin tumors in acromegaly.
    Varlamov EV; Wood MD; Netto JP; Thiessen J; Kim J; Lim DST; Yedinak CG; Banskota S; Cetas JS; Fleseriu M
    Pituitary; 2020 Dec; 23(6):672-680. PubMed ID: 32870441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI texture analysis in acromegaly and its role in predicting response to somatostatin receptor ligands.
    Galm BP; Buckless C; Swearingen B; Torriani M; Klibanski A; Bredella MA; Tritos NA
    Pituitary; 2020 Jun; 23(3):212-222. PubMed ID: 31897778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T2-weighted magnetic resonance imaging as a novel predictor of surgical remission in newly diagnosed pituitary macroadenomas presenting as acromegaly.
    Akkaya E; Akgun MY; Sebnem Durmaz E; Aydın S; Mefkure Ozkaya H; Comunoglu N; Kizilkilic O; Gazioglu N; Kadioglu P; Tanriover N
    J Clin Neurosci; 2021 Aug; 90():105-111. PubMed ID: 34275532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Ki-67 in acromegalic patients with hyperprolactinemia: retrospective analysis in 61 Chinese Patients.
    Huan C; Cui G; Lu C; Qu X; Han T
    Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):719-23. PubMed ID: 25796164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: a study on 184 patients.
    Lampropoulos KI; Samonis G; Nomikos P
    Hormones (Athens); 2013; 12(2):254-64. PubMed ID: 23933694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
    Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
    Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas.
    Dogansen SC; Yalin GY; Tanrikulu S; Tekin S; Nizam N; Bilgic B; Sencer S; Yarman S
    Pituitary; 2018 Aug; 21(4):347-354. PubMed ID: 29460202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical detection of glycoprotein hormone alpha subunit in somatoprolactinic and pure somatotroph adenomas.
    Vantyghem MC; Cortet C; Bauters C; Gevaert MH; Dewailly D; Lefebvre J; Mazzucca M
    J Endocrinol Invest; 1998; 21(7):434-40. PubMed ID: 9766257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paradoxical GH Increase During OGTT Is Associated With First-Generation Somatostatin Analog Responsiveness in Acromegaly.
    Scaroni C; Albiger N; Daniele A; Dassie F; Romualdi C; Vazza G; Regazzo D; Ferraù F; Barresi V; Maffeis V; Gardiman MP; Cannavò S; Maffei P; Ceccato F; Losa M; Occhi G
    J Clin Endocrinol Metab; 2019 Mar; 104(3):856-862. PubMed ID: 30285115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
    Hofstetter CP; Mannaa RH; Mubita L; Anand VK; Kennedy JW; Dehdashti AR; Schwartz TH
    Neurosurg Focus; 2010 Oct; 29(4):E6. PubMed ID: 20887131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of specific growth patterns and frequency of the empty sella phenomenon in growth hormone-secreting pituitary adenomas.
    Bier G; Hempel JM; Grimm F; Ernemann U; Bender B; Honegger J
    Eur J Radiol; 2018 Jul; 104():79-86. PubMed ID: 29857870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of postoperative biochemical remission in lower Knosp grade growth hormone-secreting pituitary adenomas: a large single center study.
    Zhang S; Chen J; Yao S; Akter F; Wang Z; Hu B; Zhu D; Duan C; Chen W; Zhu Y; Wang H; Mao Z
    J Endocrinol Invest; 2023 Mar; 46(3):465-476. PubMed ID: 36125731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas.
    Campbell PG; Kenning E; Andrews DW; Yadla S; Rosen M; Evans JJ
    Neurosurg Focus; 2010 Oct; 29(4):E5. PubMed ID: 20887130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical Management of Carney Complex-Associated Pituitary Pathology.
    Lonser RR; Mehta GU; Kindzelski BA; Ray-Chaudhury A; Vortmeyer AO; Dickerman R; Oldfield EH
    Neurosurgery; 2017 May; 80(5):780-786. PubMed ID: 27509071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: outcome analysis and determinants of failure.
    Tindall GT; Oyesiku NM; Watts NB; Clark RV; Christy JH; Adams DA
    J Neurosurg; 1993 Feb; 78(2):205-15. PubMed ID: 8421204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature.
    Almeida JP; Ruiz-Treviño AS; Liang B; Omay SB; Shetty SR; Chen YN; Anand VK; Grover K; Christos P; Schwartz TH
    J Neurosurg; 2018 Aug; 129(2):404-416. PubMed ID: 28862548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substantial shrinkage of adenomas cosecreting growth hormone and prolactin with use of cabergoline therapy.
    Vilar L; Czepielewsk MA; Naves LA; Rollin GA; Casulari LA; Coelho CE
    Endocr Pract; 2007; 13(4):396-402. PubMed ID: 17669717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.